Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction.
Sala
Mariaelvina
M
Department of Pharmacology, Chemotherapy and medical Toxicology, Faculty of Sciences, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy. mariaelvina.sala@unimi.it
Braida
Daniela
D
D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000494:pharmacology*; D002188:Cannabis; D004347:Drug Interactions; D063388:Endocannabinoids; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology*; D020258:Neurotoxicity Syndromes / Q000503:physiopathology; D012054:Reinforcement, Psychology; D012201:Reward
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine